Clinical Trial Update: Renal Atherosclerotic Revascularization Evaluation: RAVE Study [NA]

View source ↗

Summary

Renal Atherosclerotic Revascularization Evaluation (RAVE) study has completed. The trial concerns hypertension due to renovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Renovascular Hypertension

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Hypertension, Renovascular | NA | Status: COMPLETED